6468 related articles for article (PubMed ID: 20873143)
1. [T-cadherin suppresses the cell proliferation of mouse melanoma B16F10 and tumor angiogenesis in the model of the chorioallantoic membrane].
Iurlova EI; Rubina KA; Sysoeva VIu; Sharonov GV; Semina EV; Parfenova EV; Tkachuk VA
Ontogenez; 2010; 41(4):261-70. PubMed ID: 20873143
[TBL] [Abstract][Full Text] [Related]
2. Use of multicellular tumor spheroids to dissect endothelial cell-tumor cell interactions: a role for T-cadherin in tumor angiogenesis.
Ghosh S; Joshi MB; Ivanov D; Feder-Mengus C; Spagnoli GC; Martin I; Erne P; Resink TJ
FEBS Lett; 2007 Sep; 581(23):4523-8. PubMed ID: 17765896
[TBL] [Abstract][Full Text] [Related]
3. The chick embryo chorioallantoic membrane in the study of tumor angiogenesis.
Ribatti D
Rom J Morphol Embryol; 2008; 49(2):131-5. PubMed ID: 18516317
[TBL] [Abstract][Full Text] [Related]
4. BF-30 selectively inhibits melanoma cell proliferation via cytoplasmic membrane permeabilization and DNA-binding in vitro and in B16F10-bearing mice.
Wang H; Ke M; Tian Y; Wang J; Li B; Wang Y; Dou J; Zhou C
Eur J Pharmacol; 2013 May; 707(1-3):1-10. PubMed ID: 23541725
[TBL] [Abstract][Full Text] [Related]
5. Effects of Monascus-fermented rice extract on malignant cell-associated neovascularization and intravasation determined using the chicken embryo chorioallantoic membrane model.
Ho BY; Wu YM; Hsu YW; Hsu LC; Kuo YH; Chang KJ; Pan TM
Integr Cancer Ther; 2010 Jun; 9(2):204-12. PubMed ID: 20356949
[TBL] [Abstract][Full Text] [Related]
6. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
[TBL] [Abstract][Full Text] [Related]
7. H-cadherin expression reduces invasion of malignant melanoma.
Kuphal S; Martyn AC; Pedley J; Crowther LM; Bonazzi VF; Parsons PG; Bosserhoff AK; Hayward NK; Boyle GM
Pigment Cell Melanoma Res; 2009 Jun; 22(3):296-306. PubMed ID: 19368692
[TBL] [Abstract][Full Text] [Related]
8. Selection of metastatic variants from heterogeneous tumor cell lines using the chicken chorioallantoic membrane and nude mouse.
Dexter DL; Lee ES; DeFusco DJ; Libbey NP; Spremulli EN; Calabresi P
Cancer Res; 1983 Apr; 43(4):1733-40. PubMed ID: 6831418
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of malignancy-associated laminins and laminin receptors by angiotropic human melanoma cells in a chick chorioallantoic membrane model.
Lugassy C; Torres-Muñoz JE; Kleinman HK; Ghanem G; Vernon S; Barnhill RL
J Cutan Pathol; 2009 Dec; 36(12):1237-43. PubMed ID: 19469865
[TBL] [Abstract][Full Text] [Related]
10. Expression, purification, and bioactivity of human tumstatin from Escherichia coli.
Gu Q; Zhang T; Luo J; Wang F
Protein Expr Purif; 2006 Jun; 47(2):461-6. PubMed ID: 16503164
[TBL] [Abstract][Full Text] [Related]
11. Novel anti-denatured collagen humanized antibody D93 inhibits angiogenesis and tumor growth: An extracellular matrix-based therapeutic approach.
Pernasetti F; Nickel J; Clark D; Baeuerle PA; Van Epps D; Freimark B
Int J Oncol; 2006 Dec; 29(6):1371-9. PubMed ID: 17088974
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human interleukin-24 suppresses gastric carcinoma cell growth in vitro and in vivo.
Yan S; Zhang H; Xie Y; Sheng W; Xiang J; Ye Z; Chen W; Yang J
Cancer Invest; 2010 Jan; 28(1):85-93. PubMed ID: 19916746
[TBL] [Abstract][Full Text] [Related]
13. Tumor angiogenesis and polyamines: alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro.
Takigawa M; Enomoto M; Nishida Y; Pan HO; Kinoshita A; Suzuki F
Cancer Res; 1990 Jul; 50(13):4131-8. PubMed ID: 1693880
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of H/T-cadherin in tumor-penetrating blood vessels.
Wyder L; Vitaliti A; Schneider H; Hebbard LW; Moritz DR; Wittmer M; Ajmo M; Klemenz R
Cancer Res; 2000 Sep; 60(17):4682-8. PubMed ID: 10987267
[TBL] [Abstract][Full Text] [Related]
15. The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo.
Vandercappellen J; Liekens S; Bronckaers A; Noppen S; Ronsse I; Dillen C; Belleri M; Mitola S; Proost P; Presta M; Struyf S; Van Damme J
Mol Cancer Res; 2010 Mar; 8(3):322-34. PubMed ID: 20215425
[TBL] [Abstract][Full Text] [Related]
16. Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.
Yalcin M; Bharali DJ; Lansing L; Dyskin E; Mousa SS; Hercbergs A; Davis FB; Davis PJ; Mousa SA
Anticancer Res; 2009 Oct; 29(10):3825-31. PubMed ID: 19846915
[TBL] [Abstract][Full Text] [Related]
17. Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I.
Chen MJ; Chiou PP; Lin P; Lin CM; Siri S; Peck K; Chen TT
J Cell Biochem; 2007 Aug; 101(5):1316-27. PubMed ID: 17286280
[TBL] [Abstract][Full Text] [Related]
18. The 18 kDa isoform of basic fibroblast growth factor is sufficient to stimulate human melanoma growth and angiogenesis.
Fontijn D; Duyndam MC; Beliën JA; Gallegoz Ruiz MI; Pinedo HM; Boven E
Melanoma Res; 2007 Jun; 17(3):155-68. PubMed ID: 17505261
[TBL] [Abstract][Full Text] [Related]
19. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
[TBL] [Abstract][Full Text] [Related]
20. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
Nagai H; Horikawa T; Hara I; Fukunaga A; Oniki S; Oka M; Nishigori C; Ichihashi M
Exp Dermatol; 2004 Oct; 13(10):613-20. PubMed ID: 15447721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
